Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.37%293.72B | 13.75%1.2T | 11.02%273.56B | -0.92%1.06T | 3.86%291.23B | 0.30%262.19B | -2.85%256.7B | -5.33%246.41B | 14.60%1.07T | 8.03%280.41B |
| Cost of revenue | 5.10%244.29B | 11.42%1T | 9.35%232.43B | -1.33%897.54B | 2.30%241.61B | -1.29%220.79B | -1.64%222.58B | -4.88%212.55B | 14.88%909.62B | 6.57%236.18B |
| Gross profit | 20.18%49.42B | 26.87%201.72B | 21.46%41.13B | 1.46%158.99B | 12.19%49.62B | 9.78%41.4B | -10.08%34.12B | -8.05%33.86B | 12.99%156.7B | 16.53%44.23B |
| Operating expense | 8.97%40.98B | 4.60%154.62B | 2.64%37.6B | 4.64%147.82B | 8.82%37.89B | 2.97%37.34B | 4.44%35.95B | 2.46%36.64B | 11.00%141.26B | 10.18%34.82B |
| Selling and administrative expenses | 8.97%40.98B | 4.60%154.62B | 2.64%37.6B | 4.64%147.82B | 8.82%37.89B | 2.97%37.34B | 4.44%35.95B | 2.46%36.64B | 11.00%141.26B | 10.18%34.82B |
| -Selling and marketing expense | 6.59%11.42B | -7.61%45.28B | -1.59%10.71B | 2.69%49.02B | 13.37%13.4B | -0.19%12.34B | 3.07%12.39B | -5.56%10.89B | 22.86%47.73B | 17.25%11.82B |
| -General and administrative expense | 9.92%29.56B | 10.66%109.34B | 4.42%26.89B | 5.64%98.81B | 6.49%24.49B | 4.61%25B | 5.18%23.57B | 6.28%25.75B | 5.79%93.53B | 6.87%23B |
| Operating profit | 139.81%8.45B | 321.57%47.1B | 226.74%3.52B | -27.65%11.17B | 24.65%11.73B | 180.37%4.06B | -152.07%-1.83B | -360.69%-2.78B | 35.12%15.44B | 48.06%9.41B |
| Net non-operating interest income (expenses) | -0.77%-1.95B | -8.99%-8.03B | -15.64%-1.94B | -40.54%-7.36B | -2.60%-1.9B | -32.67%-1.88B | -71.33%-1.91B | -95.22%-1.68B | -85.39%-5.24B | -131.87%-1.85B |
| Non-operating interest income | -24.01%250M | -36.16%1.2B | -34.72%329M | 71.23%1.88B | 7.53%471M | 90.64%509M | 77.73%391M | 196.47%504M | 99.45%1.1B | 268.07%438M |
| Non-operating interest expense | -2.82%2.2B | -0.17%9.22B | 3.99%2.27B | 45.85%9.24B | 3.54%2.37B | 41.86%2.39B | 72.38%2.3B | 111.96%2.18B | 87.67%6.33B | 149.56%2.29B |
| Net investment income | -162.17%-1.02B | 350.85%4.75B | -6.21%1.65B | -65.90%1.05B | 56.67%998M | 5.95%-2.91B | -39.42%1.21B | -50.56%1.76B | -0.51%3.09B | -49.92%637M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | -30.74%7.81B | -154.74%-1.32B | -24.49%11.27B | 362.47%8.6B | -105.47%-702M | 412.23%963M | 5,246.67%2.41B | 702.74%14.92B | 42.31%1.86B |
| Income from associates and other participating interests | -53.43%2.1B | 67.67%10.6B | 334.43%4.51B | 75.15%6.32B | 171.07%1.5B | 431.59%2.66B | 521.43%1.13B | -71.79%1.04B | -60.09%3.61B | -81.53%553M |
| Special income (charges) | 78.74%-111M | -381.43%-7.08B | -347.39%-522M | 65.48%-1.47B | 90.36%-303M | -31.90%-1.32B | 88.27%-55M | -40.56%211M | -288.59%-4.26B | -224.25%-3.14B |
| Less:Other special charges | -78.74%111M | -278.70%-1.65B | 347.39%522M | -78.28%925M | -107.70%-242M | 31.90%1.32B | -88.27%55M | 40.56%-211M | 257.97%4.26B | 518.93%3.14B |
| Less:Write off | ---- | 1,501.83%8.73B | ---- | --545M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 129.75%205M | -16.14%-1.07B | -388.65%-689M | -359.77%-917M | -42.86%-350M | -103.14%-16M | -91.59%-410M | -146.53%-141M | 132.39%353M | 42.08%-245M |
| Income before tax | 47.04%7.66B | 169.58%54.09B | 539.39%5.21B | -28.14%20.06B | 180.69%20.27B | -101.40%-119M | -122.17%-906M | -89.99%815M | 36.67%27.92B | -25.83%7.22B |
| Income tax | 716.90%1.79B | 44.63%16.76B | -112.05%-290M | 12.62%11.59B | 393.82%6.31B | -51.83%1.64B | -54.91%1.23B | -16.45%2.41B | 43.10%10.29B | -29.24%1.28B |
| Net income | 6.72%5.87B | 340.43%37.33B | 445.60%5.5B | -51.93%8.48B | 134.89%13.96B | -134.77%-1.76B | -256.26%-2.13B | -130.28%-1.59B | 33.17%17.63B | -25.07%5.94B |
| Net income continuous operations | 6.76%5.87B | 340.38%37.33B | 445.54%5.5B | -51.92%8.48B | 134.87%13.96B | -134.78%-1.76B | -256.26%-2.13B | -130.27%-1.59B | 33.17%17.63B | -25.06%5.95B |
| Noncontrolling interests | -13.44%715M | 101.42%3.96B | 612.07%826M | 13.30%1.97B | 7.89%930M | 6.92%618M | -1.62%304M | 1,066.67%116M | -44.77%1.74B | -27.13%862M |
| Net income attributable to the company | 10.27%5.16B | 412.69%33.37B | 373.77%4.68B | -59.05%6.51B | 156.45%13.03B | -153.03%-2.38B | -330.87%-2.44B | -132.41%-1.71B | 57.48%15.89B | -24.70%5.08B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 10.27%5.16B | 412.69%33.37B | 373.77%4.68B | -59.05%6.51B | 156.45%13.03B | -153.03%-2.38B | -330.87%-2.44B | -132.41%-1.71B | 57.48%15.89B | -24.70%5.08B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 10.26%73.18 | 412.44%473.49 | 373.47%66.37 | -59.08%92.4 | 156.30%185.05 | -152.99%-33.77 | -330.89%-34.61 | -132.41%-24.27 | 57.46%225.8 | -24.71%72.2 |
| Diluted earnings per share | 10.26%73.18 | 412.44%473.49 | 373.47%66.37 | -59.08%92.4 | 156.22%184.9733 | -152.99%-33.77 | -331.04%-34.6332 | -132.41%-24.27 | 57.46%225.8 | -24.71%72.1927 |
| Dividend per share | 0 | 100.00%120 | 0 | -25.00%60 | -25.00%60 | 0 | 0 | 0 | 33.33%80 | 33.33%80 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |